Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Long-term efficacy of 10-12 years after being immunized with Chinese hamster ovary cell derived hepatitis B vaccine in Chinese Rural Communities.
Wang F, Zhao YL, Ma JC, Bi SL, Zhang Y, Shen LP.
Vaccine. 2012 Mar 9;30(12):2051-3. Epub 2012 Jan 30.
Related citations
Virus-like particles of hepatitis B virus core protein containing five mimotopes of infectious bursal disease virus (IBDV) protect chickens against IBDV.
Wang YS, Ouyang W, Liu XJ, He KW, Yu SQ, Zhang HB, Fan HJ, Lu CP.
Vaccine. 2012 Mar 9;30(12):2125-30. Epub 2012 Jan 26.
Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
Fabrizi F, Dixit V, Messa P, Martin P.
Vaccine. 2012 Mar 16;30(13):2295-300. Epub 2012 Jan 26.
Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.
Ott JJ, Stevens GA, Groeger J, Wiersma ST.
Vaccine. 2012 Mar 9;30(12):2212-9. Epub 2012 Jan 24.
Hepatitis B vaccination coverage and uptake in prisons across England and Wales 2003-2010: a retrospective ecological study.
Beck CR, Cloke R, O'Moore É, Puleston R.
Vaccine. 2012 Mar 2;30(11):1965-71. Epub 2012 Jan 18.
Persistence of long-term immunity to hepatitis B among adolescents immunized at birth.
Chaves SS, Fischer G, Groeger J, Patel PR, Thompson ND, Teshale EH, Stevenson K, Yano VM, Armstrong GL, Samandari T, Kamili S, Drobeniuc J, Hu DJ.
Vaccine. 2012 Feb 21;30(9):1644-9. Epub 2012 Jan 11.
Safety and immunogenicity of a modified process hepatitis B vaccine in healthy neonates.
Minervini G, McCarson BJ, Reisinger KS, Martin JC, Stek JE, Atkins BM, Nadig KB, Liska V, Schödel FP, Bhuyan PK.
Vaccine. 2012 Feb 14;30(8):1476-80. Epub 2012 Jan 5.
Prevention of perinatal hepatitis B virus transmission in the Netherlands, 2003-2007: children of Chinese mothers are at increased risk of breakthrough infection.
Hahné S, van den Hoek A, Baayen D, van der Sande M, de Melker H, Boot H.
Vaccine. 2012 Feb 21;30(9):1715-20. Epub 2011 Dec 30.
Reply to "Preparing for the next public debate: universal vaccination against hepatitis B".
van Rijswoud E.
Vaccine. 2012 Apr 5;30(17):2709. Epub 2011 Dec 14. No abstract available.
Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease.
Zitt E, Sprenger-Mähr H, Knoll F, Neyer U, Lhotta K.
Vaccine. 2012 Jan 20;30(5):931-5. Epub 2011 Dec 4.
Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process.
Sharma HJ, Patil VD, Lalwani SK, Manglani MV, Ravichandran L, Kapre SV, Jadhav SS, Parekh SS, Ashtagi G, Malshe N, Palkar S, Wade M, Arunprasath TK, Kumar D, Shewale SD.
Vaccine. 2012 Jan 11;30(3):510-6. Epub 2011 Nov 26.
Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users.
Tran TQ, Grimes CZ, Lai D, Troisi CL, Hwang LY.
Vaccine. 2012 Jan 5;30(2):342-9. Epub 2011 Nov 8.
Progress in newborn hepatitis B vaccination by birth year cohorts-1998-2007, USA.
Zhao Z, Murphy TV, Jacques-Carroll L.
Vaccine. 2011 Dec 9;30(1):14-20. Epub 2011 Nov 7.
Immunogenicity of hepatitis B vaccine among hemodialysis patients: effect of revaccination of non-responders and duration of protection.
Chaves SS, Daniels D, Cooper BW, Malo-Schlegel S, Macarthur S, Robbins KC, Kobetitsch JF, McDaniel A, D'Avella JF, Alter MJ.
Vaccine. 2011 Dec 6;29(52):9618-23. Epub 2011 Oct 30.
New neutralizing antibody epitopes in hepatitis C virus envelope glycoproteins are revealed by dissecting peptide recognition profiles.
Kachko A, Kochneva G, Sivolobova G, Grazhdantseva A, Lupan T, Zubkova I, Wells F, Merchlinsky M, Williams O, Watanabe H, Ivanova A, Shvalov A, Loktev V, Netesov S, Major ME.
Vaccine. 2011 Dec 9;30(1):69-77. Epub 2011 Oct 29.
Universal screening for hepatitis B among pregnant women led to 96% vaccination coverage among newborns of HBsAg positive mothers in Denmark.
Harder KM, Cowan S, Eriksen MB, Krarup HB, Christensen PB.
Vaccine. 2011 Nov 21;29(50):9303-7. Epub 2011 Oct 19.
Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities.
Tohme RA, Awosika-Olumo D, Nielsen C, Khuwaja S, Scott J, Xing J, Drobeniuc J, Hu DJ, Turner C, Wafeeg T, Sharapov U, Spradling PR.
Vaccine. 2011 Nov 21;29(50):9316-20. Epub 2011 Oct 18.
Evaluating functional antibodies in rhesus monkeys immunized with hepatitis B virus surface antigen vaccine with novel adjuvant formulations.
Freed DC, Towne VM, Casimiro DR, Zhao Q, Fu TM.
Vaccine. 2011 Nov 21;29(50):9385-90. Epub 2011 Oct 11.
Immunogenicity and tolerability of a paediatric presentation of a virosomal hepatitis A vaccine in Chilean children aged 1-16 years.
Abarca K, Ibáñez I, de la Fuente P, Cerda L, Bergeret J, Frösner G, Ibarra H.
Vaccine. 2011 Nov 8;29(48):8855-62. Epub 2011 Oct 6.
Burden and prevention of viral hepatitis in Bulgaria.
Fitzsimons D, Kojouharova M, Hallauer J, Hendrickx G, Vorsters A, Van Damme P.
Vaccine. 2011 Nov 3;29(47):8471-6. Epub 2011 Sep 25.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on